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Abstract Availability of voltage-gated calcium channels
(Cav) at the plasma membrane is paramount to maintaining
the calcium homeostasis of the cell. It is proposed that the
ubiquitylation/de-ubiquitylation balance regulates the density
of ion channels at the cell surface. Voltage-gated calcium
channels Cav1.2 have been found to be ubiquitylated under
basal conditions both in vitro and in vivo. In a previous study,
we have shown that Cav1.2 channels are ubiquitylated by
neuronal precursor cell-expressed developmentally downreg-
ulated 4 (Nedd4-1) ubiquitin ligases, but the identity of the
counterpart de-ubiquitylating enzyme remained to be eluci-
dated. Regarding sodium and potassium channels, it has been
reported that the action of the related isoform Nedd4-2 is
counteracted by the ubiquitin-specific protease (USP) 2-45.
In this study, we show that USP 2-45 also de-ubiquitylates Cav
channels. We co-expressed USPs and Cav1.2 channels togeth-
er with the accessory subunits β2 and α2δ-1, in tsA-201 and
HEK-293 mammalian cell lines. Using whole-cell current
recordings and surface biotinylation assays, we show that
USP2-45 specifically decreases both the amplitude of Cav
currents and the amount of Cav1.2 subunits inserted at the
plasma membrane. Importantly, co-expression of the α2δ-1
accessory subunit is necessary to support the effect of USP2-
45. We further show that USP2-45 promotes the de-
ubiquitylation of both Cav1.2 and α2δ-1 subunits. Remark-
ably, α2δ-1, but not Cav1.2 nor β2, co-precipitated with
USP2-45. These results suggest that USP2-45 binding to
α2δ-1 promotes the de-ubiquitylation of both Cav1.2 and
α2δ-1 subunits, in order to regulate the expression of Cav1.2
channels at the plasma membrane.
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Abbreviations
USPs Ubiquitin-specific proteases
Cav Voltage-gated calcium channel
Introduction
Ubiquitylation is a post-translational modification which has
been shown to regulate the availability of both intracellular
and membrane proteins [1, 35]. Ubiquitin, a small protein of
8 kDa, is attached by ubiquitin ligases onto lysine residues of
target proteins. Equally important is the reverse process oper-
ated by de-ubiquitylases (DUBs) [29, 32]. The ubiquitylation
and therefore the fate of the targeted proteins result from the
balanced action of both families of enzymes. A multitude of
ubiquitin ligases and de-ubiquitylases have already been
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identified, and one current challenge is to identify their asso-
ciated targets. The human genome encodes for more than 100
de-ubiquitylases [29, 32]. They have been classified into five
families according to the active sites used to perform the de-
ubiquitylation process: cysteine or zinc active sites. The zinc
active site is found in JAB1/MPN/MOV34 metalloenzymes,
and the cysteine active site is found in ubiquitin C-terminal
hydrolase, ovarian tumour proteases, Machado-Josephin do-
mains and ubiquitin-specific proteases (USPs) [29, 32]. Inter-
estingly, USP2-45 had been shown to de-ubiquitylate the
epithelial sodium channel (ENaC) [38] and regulate its ex-
pression at the plasma membrane. The same research group
further reported that USP2-45 physically interacts with the
neuronal precursor cell-expressed developmentally downreg-
ulated 4 (Nedd4-2) ubiquitin ligases [30] known to
ubiquitylate ENaC [24, 44]. Moreover, both USP2-45 and
USP2-69 counteracted the Nedd4-2-mediated ubiquitylation
of cardiac potassium channels [26]. We have previously
shown that another closely related isoform, Nedd4-1,
ubiquitylates Cav1.2 channels [36]. In spite of Nedd4-1 and
Nedd4-2 having selective targets [24, 36], these studies sug-
gest that there may be a reciprocity between the two families
of Nedd4 ubiquitin ligases and USP de-ubiquitylases, which
lead us to firstly investigate USP2-45 as a potential regulator
of Cav1.2 channels. USP2-45 is one of the two isoforms
encoded by the USP2 gene which is alternatively spliced to
give USP2-45 (45 kDa) and USP2-69 (69.5 kDa) [29]. Both
splice variants share an identical catalytic core, but USP2-69
has a longer N-terminal domain which may possibly regulate
USP2-69 subcellular localization or act as an auto-inhibitory
domain [30]. Gousseva and Baker have shown that USP2-45
and USP2-69 messenger RNAs (mRNAs) are expressed to-
gether in mouse testis, skeletal muscle and heart [22]. USP2-
45 mRNA is also present in the brain, liver and kidney [22].
Increased expression of USP2 was reported in prostate tu-
mours [31]. Tissue expression of USP2 can also be modulated
by signalling pathways, as shown by Fakitsas et al. [15] who
demonstrated that aldosterone induces the expression of
USP2-45 in the cortical collecting duct of the kidney.
Our study investigates whether USP2 regulates voltage-
gated calcium Cav1.2 channels. These widely expressed chan-
nels constitute the main pathway for calcium entry into vas-
cular and cardiac myocytes and are a major target for the
treatment of cardiovascular diseases [27, 40]. Cav1.2 channels
also contribute to neuron excitability and are involved in the
control of gene transcription [13]. In addition to the main
pore-forming Cav1.2 subunit, Cav1.2 channels also contain
accessory subunits: β and α2δ, which regulate both the gating
properties and trafficking of the channels [9, 41, 17, 7, 6].
Cav1.2 channels are predominantly associated with β2 [10,
43] and α2δ-1 [5, 28] in the heart. We, and others, have
previously shown that these three Cav1.2 subunits are
ubiquitylated in vitro and in vivo [25, 36]. Here, we found
that both USP2-45 and USP2-69 regulate cloned cardiac
Cav1.2 channels expressed in mammalian cell lines. The main
difference between the two USP2 isoforms resides in their N-
terminal domain which was suggested to direct target speci-
ficity [30] as reported for ENaC channels which are not
sensitive to USP2-69 [15]. The similar reduction of Cav cur-
rents obtained with either splice variant suggests that Cav
channels are the target of both isoforms and that the minimum
sequence required for Cav current reduction resides within the
short variant form of USP. Hence, we focussed our investiga-
tion on USP2-45-induced regulation of Cav channels. Our
study reveals a new role for α2δ-1 subunits in binding
USP2-45 and promoting the de-ubiquitylation of both α1
and α2δ-1 subunits. USP2-45-induced Cav regulation leads
to a decrease of Cav1.2 channels available at the plasma
membrane.
Methods
DNA constructs
Rabbit Cav1.2 (cardiac isoform α1c) (P15381.1), β2b
(P54288) and α2δ-1a (P13806) complementary DNAs
(cDNAs) subcloned into pCARDHE, pBH17 and pCA1S,
respectively, were gifts from Dr. G.S. Pitt (Department of
Medicine, Division of Cardiology, Duke University Medical
Center, Durham, NC, USA). Mouse USP2-45 (NM 198091)
with and without S-tag and the mutant USP2-45C67A cDNAs
subcloned into pcDNA3.1 were gifts from Prof. O. Staub
(Department of Pharmacology and Toxicology, Lausanne,
Switzerland).
Transfections
For electrophysiological studies, T25-cm2 flasks of tsA-201
cells were transiently co-transfected using Fugene® 6 mix
reagent (Roche Diagnostics, IN, USA) with 0.3 μg of each
subunit of voltage-gated calcium channel (Cav1.2, β2 and
α2δ-1 subunits; ratio 1:1:1) and 1.0 μg of other constructs or
empty vector. An equivalent amount of pcDNA3.1 DNAwas
added to the transfection mix to compensate for the absence of
DNA encoding Cav subunits or USPs when omitted. All
transfections included 0.5 μg of cDNA encoding CD8 antigen
as a reporter gene. Anti-CD8 beads (Dynal®, Oslo, Norway)
were used to identify transfected cells, and only decorated
cells were analysed. For biochemistry experiments, T75-cm2
flasks of HEK-293 cells were transfected using Lipofectamine
LTX® (Invitrogen, Basel, Switzerland) according to the man-
ufacturer’s instructions. The ratio of cDNAs/Lipofectamine
was 10 μg cDNAs/30 μl Lipofectamine. The ratio of the
different constructs was similar to those used in patch clamp
experiments. In biochemistry experiments, an additional
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control was performed by using the empty vector pcDNA3.1
only in Cav-untransfected cells. Cells were used 48 h after
transfection.
Electrophysiology
Whole-cell currents were measured at room temperature (22–
23 °C) using an Axopatch200B amplifier (Axon Instruments,
Union City, CA, USA). TsA-201 cells were replated 24 h post-
transfection onto 35-mm plastic Petri dishes and recorded from
24 h post-replating. The internal pipette solutionwas composed
of (in mM) 60 CsCl, 70 cesium aspartate, 1MgCl2, 10 HEPES,
11 EGTA and 5 Mg-ATP, pH 7.2 with CsOH. The external
solution contained (in mM) 130 NaCl, 5.6 KCl, 5 to 20 BaCl2,
1 MgCl2, 10 HEPES and 11 D-glucose, pH 7.4 with NaOH.
The osmolarity, assessed using a Löser micro-osmometer
(Giessen, Marburger, Germany), was 295 mOsm l−1 for both
the internal solution and the 5 mM BaCl2 external solution and
325 mOsm l−1 for the 20 mM BaCl2 external solution. In
experiments performed without β subunits which are known
to promote Cav targeting, we used the higher 20 mM BaCl2
solution to compensate for the lack of β subunits which greatly
reduced Cav currents. 5 mM BaCl2 was used for all other
experiments. Data were analysed using pClamp software, ver-
sion 9.2 (Axon Instruments, Union City, CA, USA), andOrigin
software, version 7.5 (OriginLab® corporation, Northampton,
MD, USA). Barium current densities (pA/pF) were calculated
by dividing the peak current by the cell capacitance. I-V
relationship (IV) were fitted with the following equation
I=(g(Vh−Vrev))/(1+exp[(Vh−V50)/k]), in which I is the nor-
malized peak current density (pA/pF) at a given holding po-
tential (Vh), V50,act is the voltage at which half of the channels
are activated, k is the slope factor, Vrev is the reversal potential
and g is the conductance. The maximal conductance Gmax was
calculated from the maximal peak current density.
Western blots
T75-cm2 flasks of HEK-293 cells were lysed in 1.0 ml of lysis
buffer (50 mMHEPES pH 7.4, 150 mMNaCl, 10 % glycerol,
1 % triton, 1 mM EGTA supplemented with 10 mM N-
ethylmaleimide and protease inhibitors). Protein concentra-
tion was systematically determined by performing a Bradford
assay (Coo protein dosage kit; Interchim,Montluçon, France).
Eighty micrograms of proteins were loaded on an SDS-PAGE
gel. Protein transfer was done with the dry system transfer
iBlot® from Invitrogen (Invitrogen, Basel, Switzerland). Im-
munoblotting was accomplished by using the SNAP id®
system of Millipore (Millipore, Zug, Switzerland). Fluores-
cent secondary antibodies were used, and detection was real-
ized using the LICOR system® (Lincoln, USA). The intensity
of the bands was quantified with the Odyssey software
(LICOR).
Surface biotinylation assay
HEK-293 cells were washed twice with PBS 1×, 48 h after
transfection, and then treated for 30min at 4 °Cwith 4 ml non-
permeant biotin per T75-cm2 flasks (1 mg/ml; EZ link Sulfo-
NHS-SS-Biotin; Pierce, Rockford, USA). Biotin binds to the
lysine residues of proteins exposed to the extracellular medi-
um. Cells were washed three times with cold PBS 1× contain-
ing 0.2 M glycine and lysed with 1 ml/dish of lysis buffer. The
cells were solubilized for 1 h on a wheel at 4 °C and centri-
fuged for 30 min at 20,000g at 4 °C. Supernatants were
recovered, and protein concentrations were quantified by the
Bradford method. One hundred micrograms of the lysates
were used to assess the transfection efficiency. Proteins
inserted at the plasma membrane were then selectively pulled
down with 50 μl of streptavidin sepharose beads (GE
Healthcare Europe, Glattbrugg, Switzerland) added to 1 mg
of total proteins before incubation for 2 h on a wheel at 4 °C.
The beads were washed five times with lysis buffer, and beads
were resuspended in 2.5× sample buffer (Invitrogen, Basel,
Switzerland). Eluted proteins were analysed by Western blot.
Immunoprecipitation
Transiently transfected HEK-293 cells in P100 plates were
harvested after 48-h incubation and lysed with 1× cold Ubi
lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM
EGTA, pH 8.0, 10 % glycerol, 1× EDTA-free complete prote-
ase inhibitor cocktail (Roche, Mannheim, Germany); 2 mM N-
ethylmaleimide/NEM (Sigma-Aldrich, St. Louis, MO, USA);
10 mM iodoacetamide/IAA (Sigma-Aldrich, St. Louis, MO,
USA)) containing 1%TritonX-100 for 1 h at 4 °C. Cell lysates
were then centrifuged at 16,000g at 4 °C for 15 min. Two
milligrams of the supernatant (lysate) was incubated at 4 °C for
24 hwith anti-Cav1.2 channel subunits antibodies. One volume
of 1× cold Ubi lysis buffer without Triton X-100 (to obtain a
final concentration of 0.5 % Triton X-100) was also added in
the mix. On the next day, the lysate-antibody mix was trans-
ferred to a microcentrifuge tube containing 50 μg (1:1 beads to
lysis buffer ratio) of Protein G Sepharose beads (GE
Healthcare, Uppsala, Sweden) which were previously washed
three times with 1× cold Ubi lysis buffer containing 0.5 %
Triton X-100. After adding fresh 1× EDTA-free complete
protease inhibitor cocktail, the mix was incubated overnight
at 4 °C. The beads were subsequently washed five times (4 °C;
3,000 rpm) with 1× cold Ubi buffer containing 0.3 % Triton
X-100 before elution with 50 μl of 2× NuPAGE sample buffer
with 100 mM DTT at 37 °C for 30 min. These samples are
designated as immunoprecipitation (IP) fractions. The input
fractions were resuspended with 4× NuPAGE sample buffer
with 100 mM DTT to give a concentration of 1 mg/ml and
incubated at 37 °C for 30 min. All lysis and incubation steps,
except elution in sample buffer, were performed in the dark.
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Pull down of ubiquitylated proteins
Expression of GST-S5a fusion proteins in Escherichia coli
bacteria was induced with 0.2 mM isopropyl β-D-1-thio-
galactopyranoside for 4 h at 29 °C. Cells were harvested by
centrifugation and resuspended in lysis buffer (200 mM Tris
pH 7.5, 250 mM NaCl, 1 mM EDTA, 0.5 % Igepal). Super-
natant from 15 min of centrifugation at 13,000g (4 °C) was
incubated 1 h in the presence of GSH-sepharose beads at 4 °C.
Beads were then washed three times with lysis buffer and used
in pull-down experiments. One milligram of total protein
(HEK-293 lysates) was added to 50 μg of GST-S5A beads
and incubated for 2 h at 4 °C. After washing the beads three
times with lysis buffer, precipitated proteins were eluted with
sampling buffer (Invitrogen, Basel, Switzerland) and analysed
by Western blot.
Pull down of S-tagged USP2-45
One milligram of HEK-293 cells lysate was incubated for 1 h
at 4 °Cwith 1 μl of biotinylated S-protein (Merck biosciences,
Darmstadt, Germany), followed by 1-h incubation at 4 °C
with streptavidin sepharose beads (GE Healthcare Europe,
Glattbrugg, Switzerland). The beads were washed five times
with lysis buffer, and beads were resuspended in 2.5× sample
buffer (Invitrogen, Basel, Switzerland). Eluted proteins were
analysed by Western blot.
Antibodies
Antibody against Cav1.2 (ACC003; Alomone, Jerusalem, Is-
rael) was used at a dilution of 1/200. Antibody against β2b
(ab54920; Abcam, Cambridge, UK) was used at a dilution of
1/200. Antibody against α2δ-1 (ab2864; Abcam, Cambridge,
UK) was used at a dilution of 1/1,000. FK2 antibody
was used at the dilution of 1/500 (PW8810, Enzo Life
Sciences, Lausanne, Switzerland). USP2 antibody used
at a dilution of 1/500 was a gift from Prof. O. Staub
(Department of Pharmacology and Toxicology, Lau-
sanne, Switzerland). Monoclonal antibody raised against
actin was purchased from Sigma-Aldrich (Sigma-Aldrich
Chemie, Postfach, Switzerland) and used at a dilution of
1/1,000. Antibody raised against S-tag was purchased
from Abcam (ab18588; Abcam, Cambridge, UK) and
used at a dilution of 1/200.
Statistical analysis
Two-tailed Student’s t test was used to compare two groups of
data. One-way ANOVA was used to compare three or more
groups. Data are represented as mean±SEM. P<0.05 was
considered significant.
Results
Cav1.2 currents are downregulated by USP2-45
We expressed Cav1.2 together with the accessory subunits β2
and α2δ-1 in tsA-201 cells and assessed the effect of the two
USP2 variants and USP15 on Cav currents. Figure 1 shows
that co-expressing either USP2-69 (Fig. 1a, b) or USP2-45
(Fig. 1c, d) reduced whole-cell Cav current densities (respec-
tively by 83±7 %, n=10; p<0.05 for USP2-69 at 0 mV; and
74±8 % , n=19; p<0.05 for USP2-45 at 0 mV). In contrast,
USP15, a related de-ubiquitylase [29], had no effect
(Fig. 1a, b), suggesting that Cav channels are selectively
regulated by USP2 de-ubiquitylases. The decrease in current
amplitude was not caused by a shift in the current-voltage
relationship (Fig. 1b, d) or inactivation properties of the chan-
nels (not shown). In particular, the midpoint of voltage-
dependent activation (V50,act), calculated by fitting the
current-voltage relationship as indicated in ‘Methods’, was
not significatively altered by USP2-69 (−7±3 mV versus
−10±1 mV in control; non-significant; NS) or USP2-45
(−9±4 mV versus −10±1 mV in control; NS), hence the
amplitude of the effect of either USP2 splice variant can be
directly compared at the same voltage. Interestingly, both
USP2-69 and USP2-45 significantly increased the slope factor
value (k=−9.1±0.9 in USP2-69-transfected cells versus k=
−5.9±0.3 in control; P<0.01; and k=−9.0±1.1 in USP2-45-
transfected cells versus k=−5.9±0.4 in control; P<0.05) which
suggests that de-ubiquitylation of the channels may decrease
their voltage-sensitivity. Figure 1c, d shows that the catalyti-
cally inactive mutant USP2-45C67A failed to regulate Cav1.2
channels. Current densities recorded in USP2-45C67A-
transfected cells were similar to control (control 38±5 pA/pF
at 0 mV, n=16; and USP2C67A 37±12 pA/pF at 0 mV, n=11;
NS), confirming that the effect of USP2-45 is mediated by its
de-ubiquitylating activity. Further experiments were conducted
with the USP2-45 isoform only.
USP2-45 decreases the availability of Cav1.2 channels
at the plasma membrane
A reduction of Cav current density may reflect a decrease in
the number of channels trafficked to the plasma membrane.
Hence, we examined the effect of USP2-45 on the plasma
membrane expression of Cav channels by performing surface
biotinylation assays. Figure 2a, c shows that USP2-45 reduced
the amount of biotinylated Cav1.2, whereas the surface abun-
dance of α2δ-1 and co-precipitated β2 subunits were not
affected. Remarkably, Western blots performed on the corre-
sponding whole-cell lysates showed that USP2-45 decreased
the protein amount of all three Cav subunits (Fig. 2b, d). It is
noteworthy that the cytosolic β2 is pulled down together with
the biotinylated Cav1.2 (Fig. 2a). Interestingly, the amount of
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coprecipitated β suggested that the proportion of β associated
with Cav1.2 may be increased in USP2-45-transfected cells
(by 120±32%, n=4; p<0.05 when calculating the ratio of co-
precipitated β divided by the amount of biotinylated Cav1.2).
The same comparison cannot be made regardingα2δ-1, which
is known to traffic to the cell surface independently of Cav1.2
[18, 33]. Overall, these experiments showed that USP2-45
decreases the amount of Cav1.2 channels inserted at the plas-
ma membrane and that this downregulation is correlated with
a reduction of all three (pore-forming and auxiliary) Cav
proteins.
USP2-45 promotes the de-ubiquitylation of both Cav1.2
and α2δ-1 subunits
Next, we examined the effect of USP2-45 on Cav
ubiquitylation. We immunoprecipitated Cav1.2 and detected
its level of ubiquitylation by using an FK2 anti-ubiquitin
ba
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Fig. 1 Effect of USP de-ubiquitylases on Cav1.2 currents. a Represen-
tative whole-cell current traces and b corresponding current-voltage (I-V)
relationships in Cav1.2/β2/α2δ-1 channels transfected alone with control
(white circle (control)), or with USP2-69 (black square) or USP15 (white
square) in tsA-201 cells. The maximal conductance and reversal potential
were calculated with the I-V fit described in ‘Methods’. Gmax was
specifically decreased in USP2-69 (0.3±0.2 nS/pF versus 0.8±0.1 nS/
pF in control; P<0.05), but not in USP15-transfected cells (0.8±0.2 nS/
pF; NS versus control), whilst Vrev was not modified by either USP2-69
(48±3 mV versus 54±3 mV in control; NS) or USP15 (46±3 mV; NS
versus control). The values forV50,act and slope factors are indicated in the
results section. One-way ANOVA statistical analysis compared control
with USP2-69 or USP15 (*p<0.05). The number of cells is indicated in
parentheses. aRepresentative whole-cell current traces and b correspond-
ing current-voltage relationships in tsA-201 cells transfected with Cav1.2/
β2/α2δ-1 channels alone (white circle (control)), or with USP2-45 (black
triangle) or the catalytically inactive mutant USP2-45 C67A (white
triangle). Gmax was decreased by USP2-45 (0.4±0.1 nS/pF versus 0.8±
0.1 nS/pF in control; P<0.05), but not by USP2-45 C67A (0.8±0.2 nS/
pF; NS versus control), whilst Vrev was not modified by either USP2-45
(44±4 mV versus 54±3 mV in control; NS) or USP2-45 C67A (52±
1 mV; NS versus control). The values for V50,act and slope factors are
indicated in the results section. One-way ANOVA statistical analysis
compared control with USP2-45 (*p<0.05) and USP2-45 C67A with
USP2-45 (#p<0.05). In all experiments, 5 mM BaCl2 was used to record
Cav currents
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antibody, which recognizes both mono- and poly-
ubiquitinated proteins. We found that USP2-45 reduced the
ubiquitylation status of Cav1.2 (Fig. 3a). Figure 3c shows a
significant reduction in the ratio of intensity of the signal
detected with the FK2 anti-ubiquitin antibody relative to the
total amount of immunoprecipitated Cav1.2, suggesting that
USP2-45 de-ubiquitylates Cav1.2 subunits. By contrast,
USP2-45 did not significantly alter the ubiquitylation status
of immunoprecipitated β2 subunits (Fig. 3c). Because of the
lack of sensitivity of the α2δ-1 antibody, together with the
downregulating effect of USP2-45, the amount of
immunoprecipitated subunits was low and detection of
ba
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Fig. 2 USP2-45 reduces the expression Cav1.2 channels at the plasma
membrane. a, b Surface biotinylation assays were performed in control
and USP2-45-transfected HEK-293 cells. Steptavidin-covered beads
were used to pull down the biotinylated proteins and their binding
partners. Western blots (WB) show Cav channels and USP2-45 detected
in the whole-cell lysates (a) and recovered by pull downwith streptavidin
(b) from a same experiment (n=4). Note that the cytosolic USP2-45 was
co-precipitated with the biotinylated fraction in (a), suggesting that this
de-ubiquitylase binds to proteins expressed at the plasma membrane. As
expected, the cytosolicβ2 was co-purified with the biotinylated channels,
because of their known interaction with Cav1.2. As a control, another
cytosolic protein (actin) was not recovered in the biotinylated fraction,
indicating that the membrane integrity of the cells was preserved in our
experimental conditions. c Bar graphs showing how USP2-45 alters the
amount of Cav subunits recovered in pull-down experiments. The effect
of USP2-45 was expressed as a percentage of reduction in the intensity of
Cav protein bands relative to control. USP2-45 specifically decreased the
membrane insertion of Cav1.2, whereas the amount of biotinylated α2δ-1
and the proportion of the cytosolic β2 that co-purified with the biotinyl-
ated Cav1.2 channels were unchanged. The number of independent
experiments is indicated in parentheses. NS non-significant.
***p<0.001 when compared with control. d Bar graphs showing the
USP2-45-induced decrease in the amount of total Cav proteins (both
biotinylated and non-biotinylated) recovered in the corresponding
whole-cell lysates of cells exposed to biotin. The effect of USP2-45 was
expressed as a percentage of reduction in the intensity of Cav protein
bands relative to control. The decreased amount of Cav proteins detected
in whole-cell lysates indicates that USP2-45 downregulated all three
Cav1.2, β2 and α2δ-1 subunits. **p<0.01 and ***p<0.001 when com-
pared with control
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ubiquitin on α2δ-1 was too weak to be reliably analysed using
the FK2 antibody (not shown). Hence, we used an alternative
approach and performed pull-down experiments using GST-
S5a fusion proteins, which recognize poly-ubiquitylated pro-
teins [12]. The specificity of the GST-S5a was demonstrated
in our previous works [36]. In cells transfected with the
channels only, GST-S5A pulled down all three Cav subunits,
whereas no signal was recovered in cells transfected with the
empty vector pcDNA3.1 only (Fig. 4a). This result is in line
with the fact that the three subunits are tonically ubiquitylated
in basal conditions [25, 36]. Most importantly, Fig. 4a shows
that the amount of Cav1.2 and α2δ-1 subunits recovered with
GST-S5a was drastically reduced in cells co-transfected with
USP2-45 compared to control cells transfected with the chan-
nels only. As expected from the experiments shown in
Fig. 2b, d, USP2-45 also decreased the amount of proteins
recovered in the corresponding whole-cell lysates (Fig. 4b, d).
To correct for the reduction of Cav proteins and determine the
relative change in ubiquitylation of each subunit, we
calculated the ratio of ubiquitylated versus total
(ubiquitylated and non-ubiquitylated) proteins. The ef-
fect of USP2-45 was expressed as a percentage of
change from the control value (Fig. 4c). USP2-45 sig-
nificantly decreased the ubiquitylation of Cav1.2 and
α2δ-1 but not β2 subunits. Altogether, these results
indicate that both Cav1.2 and α2δ-1, but not β2, are
regulated by the USP2-45 de-ubiquitylase.
The α2δ-1 subunit is essential for the regulation of Cav
channels by USP-45
In support of a direct effect of USP2 on the channels, we found
that USP2-45 co-immunoprecipitated with α2δ-1 but not with
Cav1.2 subunits (Fig. 5). As expected, we found no evidence
for interaction of USP2-45 with β2 subunits (Fig. 5) which are
not targeted by this de-ubiquitylase (Fig. 4a, c). These results
suggest that USP2-45 binds only to the auxiliary subunit α2δ-
1 and that this interaction is sufficient to promote the de-
ubiquitylation of both α2δ-1 and Cav1.2. To confirm the
involvement of α2δ-1, we assessed the effect of USP2-45 on
channels expressed without α2δ-1 or β subunits. We show
that, in the absence ofα2δ-1, USP2-45 did not alter Cav1.2/β2
current densities (reduced by 9±16 % at +10 mV, n=19; NS;
Fig. 6a), nor the current-voltage relationship: V50,act for
Cav1.2/β2 channels was not significantly different between
control (0.8±1.0 mV, n=11) and USP2-45-transfected cells
(−2.6±0.9 mV, n=9; NS). By contrast, USP2-45 still reduced
Cav1.2/α2δ-1 current densities in the absence of β (by 56±
19 % at +20 mV, n=9; p<0.05; Fig. 6b), again without
altering the current-voltage relationship (V50,act=6.8±
1.6 mV, n=6 in control, versus V50,act=7.7±4.6 mV, n=3;
NS; in USP2-45-transfected cells), confirming that, unlike
α2δ-1, β subunits are not required for regulation of Cav
channels by USP2-45. Altogether, these data demonstrate
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Fig. 3 De-ubiquitylation of immunoprecipitated Cav1.2 by USP2-45. a
Immunoprecipitation of Cav1.2 and b β2 subunits. Western blots were
performed to confirm the purification of Cav subunits from HEK-293
cells, whilst anti-ubiquitin FK2 antibodies were used to detect the
ubiquitylated channels. Control experiments show that Cav1.2 and β2
are tonically ubiquitylated. c Bar graph showing that USP2-45 decreased
the ubiquitylation level of Cav1.2, but not β2 subunits. The intensity of
the FK2 signal was normalized to take in account the reduction Cav
protein (i.e. dividing by the intensity of the signal obtained with the
corresponding Cav antibody), and the effect of USP2-45 was expressed
as a percentage of change from the control value
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the paramount role of α2δ-1 in USP2-45-induced downregu-
lation of Cav channels.
Discussion
In this study, we identify the de-ubiquitylase USP2-45 as a
novel regulator of Cav channels. We show that USP2-45 binds
to α2δ-1, but not Cav1.2 subunits, and that α2δ-1 is required
for USP2-45-induced Cav1.2 downregulation. This result sug-
gests that the first critical event is the binding of USP2-45 to
the auxiliary α2δ-1 subunit which may act as an anchor
allowing for USP2-45 to de-ubiquitylate Cav1.2 channels.
USP2-45 promotes the de-ubiquitylation of both Cav1.2 and
α2δ-1 subunits, reducing the availability of Cav1.2 channels at
the plasma membrane. This result is intriguing because de-
ubiquitylation is most often associated with stabilization of
proteins at the cell surface [15, 38]. Nonetheless, USP2-45
was also reported to induce the degradation of a mineralocor-
ticoid receptor, by disrupting its association with a stabilizing
partner which preferentially interacts with the ubiquitylated
form of the receptor [16]. Overexpression of USP2 was also
shown to reduce p53 stability [39], and another de-ubiquitylase
USP8 (also called UBPY) promotes epithelial growth factor
receptor degradation [4, 32, 37]. De-ubiquitylation may also
Fig. 4 USP2-45-induced de-ubiquitylation of Cav1.2 and α2δ-1
subunits. a Western blots showing the reduction of total Cav1.2, β2 and
Cavα2δ-1 proteins in HEK-293 whole-cell lysates used for b pull down of
ubiquitylated channels using ubiquitin binding GST-S5A (n=5). Note
that USP2-45 appears to reduce further the amount of Cav1.2 and α2δ-1
subunits recovered in the pull-down assay. c Bar graph comparing the
effect of USP2-45 on the ubiquitylation of the three different Cav
subunits. To illustrate that the decrease in ubiquitylation of Cav1.2 and
α2δ-1 cannot be solely explained by the concomitant reduction in total
Cav proteins, the intensity of each protein bands recovered by pull-down
assays (shown in b) was divided by the intensity of the corresponding
band in whole-cell lysates (ubiquitylated and non-ubiquitylated proteins
shown in a). The data was expressed as a percentage change of this ratio
relative to control. USP2-45 significantly decreased the ubiquitylation of
Cav1.2 and α2δ-1 but not β2 subunits. The number of experiments is
indicated in parentheses. NS non-significant. ***p<0.001 when
compared with control
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Fig. 5 USP2-45 binds to α2δ-1 subunits. Pull-down experiments were
performed on HEK-293 cells using biotinylated S-protein which recog-
nizes an S-tag epitope inserted into USP2-45. Western blots show that
USP2-45 co-precipitated withα2δ-1 but not Cav1.2 norβ2 subunits (n=3)
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serve to allow the recycling of ubiquitin moieties attached to
the proteins prior to degradation, as reported for epithelial
growth factor receptors [3, 37]. In addition, the binding of
USP2-45 to α2δ-1 may disrupt the chaperone role of this
subunit towards Cav1.2, leading to the reduction of Cav1.2
surface expression. The conserved amount of membrane-
associated α2δ-1 in USP2-45-transfected cells, revealed by
surface biotinylation assays, could be explained by the fact
that these subunits are expressed at the cell surface as both
single units and complexed with the main pore-forming Cav
α1 subunits [18, 33]. It is expected that the remaining fraction
of α2δ-1 subunits, which have not yet been sent for degrada-
tion, continues to be efficiently targeted alone to the plasma
membrane, independently of Cav1.2. Noteworthingly, α2δ-1 is
described as both transmembrane proteins [34] and extracellu-
lar glycosylphosphatidylinositol (GPI)-anchored proteins [11]
and may coexist in the two forms [11]. Because USP2-45
specifically binds to α2δ-1, one can assume that the cytosolic
USP2-45 recovered in surface biotinylation assays is co-
precipitated with the biotinylated α2δ-1 subunits. Importantly,
this result suggests that at least a fraction of α2δ-1 is a trans-
membrane protein, accessible for and able to retain the binding
of the cytosolic USP2-45. Remarkably, our study identifies
USP2-45 as a novel binding partner for α2δ-1. To date, apart
from α1 (the pore-forming subunit itself), the only other
known α2δ-1-interacting proteins were components of the
extracellular matrix called thrombospondins (TSP1, TSP2
and TSP4) [14, 21] and a subunit of a mitochondrial ATP
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Fig. 6 α2δ-1 is necessary for the USP2-45-induced decrease of Cav1.2
currents. a, b Representative whole-cell current traces and corresponding
bar graphs showing that USP2-45 failed to regulate Cav1.2 channels in
the absence of α2δ-1 subunits (a), whereas USP2-45 still decreases
Cav1.2 currents in the absence of β2 (b). tsA-201 cells were transfected
with Cav1.2/β2 alone (white circle, (control)) or together with USP2-45
(black circle) in a and Cav1.2/α2δ-1 alone (white square (control)) or
together with USP2-45 (black square) in b. As expected because of their
known involvement in Cav trafficking, the absence of either subunit
decreased Cav current densities (compared to Fig. 1). The lack of β
subunit in particular dramatically decreased Cav currents, despite the
charge carrier being increased to 20 mM BaCl2 in order to reliably
quantify the decrease caused by USP2-45 on Cav1.2/α2δ-1 channels.
The data show the amplitude of the current densities recorded at 20 mV
which generates the maximal current in the absence of β. As for prior
experiments, 5 mM BaCl2 was used to record Cav1.2/β2 currents. Cur-
rents densities are compared at 10 mV which generates the maximal
current in the absence of α2δ-1. The number of cells is indicated in
parentheses. NS non-significant. *p<0.05 when compared with respec-
tive control
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synthase complex (ATP5b) [19]. The α2δ-1 subunit also binds
to the anti-allodynic drug gabapentin used for the treatment of
neuropathic pain [20].
One intriguing finding of our study is that although the Cav
subunit β is not itself de-ubiquitylated by USP2-45, the total
amount ofβ available in USP2-45-transfected cells is reduced
together with Cav1.2 and α2δ-1. One possible explanation is
that USP2-45 preferentially regulates Cav1.2 when associated
with both accessory subunits β and α2δ-1, which may then be
concomitantly sent for degradation. Alternatively, an excess of
free β may be degraded consequently to USP2-45-induced
degradation of Cav1.2. In favour of this hypothesis, a recent
report showed that β subunits which fail to associate with
Cav2.2 are degraded by the proteasome [42]. Importantly, both
β and α2δ-1 can independently promote Cav1.2 insertion [9,
17], but only α2δ-1-associated channels are sensitive to
USP2-45. Hence, the fraction of Cav channels insensitive to
USP2-45 and able to reach the plasma membrane would be
mostly composed of Cav1.2/β channels. In favour of this
model, we found that the fraction of Cav channels expressed
at the plasma membrane of USP2-45-transfected cells is
slightly enriched in Cavβ.
In our study, we exogeneously expressed cloned cardiac Cav
channels and USP in mammalian cell lines but the extent of
such regulation and the role ofα2δ-1 in the de-ubiquitylation of
Cav channels in cardiac myocytes remain to be investigated.
The α2δ-1 subunits are also associated with Cav2 channels
which are predominantly expressed in neurons [8]. α2δ-1 was
reported to control synaptic release probability by regulating
presynaptic Cav2 channel availability [23]. Cav2 is also
ubiquitylated [2]. Hence, it would be worth assessing whether
α2δ-1 enables USP2-45, which is known to be expressed in the
brain [22], to also de-ubiquitylate neuronal Cav2 channels.
Overall, our results argue for a dual role of α2δ1 on Cav
trafficking: increasing (as previously shown [16, 7, 17]) or
decreasing Cav expression at the plasma membrane. We pro-
pose that USP2-45 acts as a switch to redirect the action ofα2δ1
towards a decrease in Cav channels availability, thus revealing a
new role both for α2δ1 and USP2-45 in calcium signalling.
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